...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
【24h】

Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.

机译:腹膜切除术联合腹膜内化学高热治疗腹膜癌的腹腔癌:I-II期研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To evaluate the feasibility and the tolerance of Peritonectomy Procedure (PP) combined with Intraperitoneal Chemohyperthermia (IPCH) in patients with peritoneal carcinomatosis, a phase I-II study has been realised from January 1997 to September 1998. METHODS: Eighteen patients were included for peritoneal carcinomatosis from colorectal cancer (13), ovarian cancer (2), gallbladder cancer (1), gastric cancer (1) and peritoneal mesothelioma (1). Peritoneal carcinomatosis were mainly advanced disease (16 stage 3 and 4, 2 stage 2). All the patients underwent surgical resection of their primary tumor with PP as described by Sugarbaker and IPCH (with Mitomycin C, Cisplatinum or both). IPCH used in this study was a "closed sterile circuit" device with inflow temperatures ranging from 46 to 48 degrees C. IPCH was performed on the same day as PP (8118) or delayed (10/18). RESULTS: Significant down-staging of peritoneal carcinomatosis was achieved for 16 patients. One patient died postoperatively, while the morbidity rate was 6/18 (long postoperative ileus, grade 3 leucopenia and anastomotic leakage). CONCLUSIONS: Combination of PP and IPCH could achieve significant tumoral volume reduction in peritoneal carcinomatosis. This aggressive treatment must be employed selectively because of its morbidity. Larger phase III studies are now needed.
机译:目的:为了评估腹膜癌切除术(PP)联合腹膜内化学性高热(IPCH)治疗腹膜癌的可行性和耐受性,从1997年1月至1998年9月进行了I-II期研究。方法:纳入18例用于大肠癌(13),卵巢癌(2),胆囊癌(1),胃癌(1)和腹膜间皮瘤(1)的腹膜癌变。腹膜癌主要是晚期疾病(16期3期和4期,2期2期)。按照Sugarbaker和IPCH(使用丝裂霉素C,顺铂或两者)对所有患者进行PP手术切除原发肿瘤。本研究中使用的IPCH是一种“封闭式无菌回路”设备,流入温度范围为46至48摄氏度。IPCH与PP(8118)在同一天进行或延迟(10/18)进行。结果:16例患者的腹膜癌分期明显降低。 1例患者术后死亡,发病率为6/18(术后肠梗阻长,3级白细胞减少和吻合口漏)。结论:PP和IPCH联合使用可显着减少腹膜癌的肿瘤体积。由于其发病率,必须选择性地采用这种积极治疗。现在需要更大的III期研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号